June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
PROSE in the pediatric population
Author Affiliations & Notes
  • Elan Aaron Rosenblat
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Kelley J Bohm
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Michelle Lee
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Kimberly C Sippel
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Cecilia Nicols
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Jessica B Ciralsky
    Ophthalmology, Weill Cornell Medical College, New York, NY
  • Footnotes
    Commercial Relationships Elan Rosenblat, None; Kelley Bohm, None; Michelle Lee, None; Kimberly Sippel, None; Cecilia Nicols, None; Jessica Ciralsky, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 6075. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Elan Aaron Rosenblat, Kelley J Bohm, Michelle Lee, Kimberly C Sippel, Cecilia Nicols, Jessica B Ciralsky; PROSE in the pediatric population. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):6075. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the tolerability and benefit of PROSE in the pediatric population.

Methods: Retrospective case series of five pediatric patients who were fit with the PROSE prosthetic device at our institution were reviewed. All patients were fit by an Optometrist who completed the Boston Foundation for Sight Clinical Fellowship in Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE). We analyzed the visual acuity at contact lens fitting, at three months and at the most recent exam (mean= 17 months) as our primary endpoints. All data was analyzed using the Student’s paired t-test.

Results: Eight eyes of 5 subjects, aged 3 to 12 years at initial visit, who underwent fitting with the PROSE prosthetic devices were reviewed. The indication for using the PROSE prosthetic device was severe ocular surface disease which was evident on exam. The average visual acuity (VA) at the initial prose fitting was 0.928 logMAR, 0.783 logMAR at 3 months, and 0.658 logMAR at the most recent visit. Initial versus most recent vision demonstrated a statistically significant improvement (p=0.01). Initial vs. 3 month (p= 0.7) did not show a statistically significant improvement. All patients were succsessfully fit by their second visit and there were no complications assoicated with PROSE use.

Conclusions: The PROSE prosthetic device has been used with success in patients with severe ocular disease. Although pediatric patients are often seen as more difficult to fit, this study demonstrates the viability and utility of using PROSE in the pediatric population.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×